Literature DB >> 11297745

Non-destructive quantitation of spermine in human prostate tissue samples using HRMAS 1H NMR spectroscopy at 9.4 T.

L L Cheng1, C Wu, M R Smith, R G Gonzalez.   

Abstract

We present the results of a study of human prostate specimens evaluated by high resolution magic angle spinning (1)H nuclear magnetic resonance (NMR) spectroscopy at 400 MHz (9.4 T) and by quantitative histopathology. We demonstrate that NMR and pathology data can be obtained from the same intact specimens, and report for the first time a linear correlation between the NMR measured concentration of spermine, a proposed endogenous inhibitor to prostate cancer growth, and the volume percentage of normal prostatic epithelial cells as quantified by histopathology. Our results show that NMR may serve as a critical tool for the investigation of the inhibitory mechanism of spermine in human subjects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11297745     DOI: 10.1016/s0014-5793(01)02329-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  45 in total

Review 1.  Magnetic resonance spectroscopy: a promising tool for the diagnostics of human prostate cancer?

Authors:  Johannes Kurth; Elita Defeo; Leo L Cheng
Journal:  Urol Oncol       Date:  2011 Sep-Oct       Impact factor: 3.498

Review 2.  Metabolomic profiling of hormone-dependent cancers: a bird's eye view.

Authors:  Stacy M Lloyd; James Arnold; Arun Sreekumar
Journal:  Trends Endocrinol Metab       Date:  2015-08-01       Impact factor: 12.015

3.  Assessing prostate cancer growth with citrate measured by intact tissue proton magnetic resonance spectroscopy.

Authors:  R Dittrich; J Kurth; E A Decelle; E M DeFeo; M Taupitz; S Wu; C-L Wu; W S McDougal; L L Cheng
Journal:  Prostate Cancer Prostatic Dis       Date:  2012-01-31       Impact factor: 5.554

4.  Two-dimensional MR spectroscopy of healthy and cancerous prostates in vivo.

Authors:  M Albert Thomas; Thomas Lange; S Sendhil Velan; Rajakumar Nagarajan; Steve Raman; Ana Gomez; Daniel Margolis; Stephany Swart; Raymond R Raylman; Rolf F Schulte; Peter Boesiger
Journal:  MAGMA       Date:  2008-07-17       Impact factor: 2.310

Review 5.  Applications of metabolomics to study cancer metabolism.

Authors:  Akash K Kaushik; Ralph J DeBerardinis
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-04-25       Impact factor: 10.680

6.  Recent Advances in Metabolic Profiling And Imaging of Prostate Cancer.

Authors:  Roopa Thapar; Mark A Titus
Journal:  Curr Metabolomics       Date:  2014-04

7.  Evaluation of the ERETIC method as an improved quantitative reference for 1H HR-MAS spectroscopy of prostate tissue.

Authors:  Mark J Albers; Thomas N Butler; Iman Rahwa; Nguyen Bao; Kayvan R Keshari; Mark G Swanson; John Kurhanewicz
Journal:  Magn Reson Med       Date:  2009-03       Impact factor: 4.668

8.  The aging effect on prostate metabolite concentrations measured by 1H MR spectroscopy.

Authors:  Monika Dezortova; Filip Jiru; Antonin Skoch; Vaclav Capek; Zuzana Ryznarova; Viktor Vik; Milan Hajek
Journal:  MAGMA       Date:  2016-08-13       Impact factor: 2.310

Review 9.  Clinical applications of metabolomics in oncology: a review.

Authors:  Jennifer L Spratlin; Natalie J Serkova; S Gail Eckhardt
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

Review 10.  High-resolution magic angle spinning 1H MRS in prostate cancer.

Authors:  Emily A Decelle; Leo L Cheng
Journal:  NMR Biomed       Date:  2013-03-26       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.